 Association of mechanical bowel preparation with oral
antibiotics and anastomotic leak following left sided
colorectal resection: an international, multi-centre,
prospective audit
The 2017 European Society of Coloproctology (ESCP) collaborating group
European Society of Coloproctology (ESCP) Cohort Studies Committee, Department of Colorectal Surgery, University of Birmingham, Birmingham, UK
Received 30 May 2018; accepted 30 July 2018
Abstract
Introduction The optimal bowel preparation strategy
to minimise the risk of anastomotic leak is yet to be
determined. This study aimed to determine whether
oral antibiotics combined with mechanical bowel prepa-
ration (MBP+Abx) was associated with a reduced risk of
anastomotic leak when compared to mechanical bowel
preparation alone (MBP) or no bowel preparation
(NBP).
Methods A pre-planned analysis of the European Society
of Coloproctology (ESCP) 2017 Left Sided Colorectal
Resection audit was performed. Patients undergoing elec-
tive left sided colonic or rectal resection with primary
anastomosis between 1 January 2017 and 15 March
2017 by any operative approach were included. The pri-
mary outcome measure was anastomotic leak.
Results Of 3676 patients across 343 centres in 47
countries, 618 (16.8%) received MBP+ABx, 1945 MBP
(52.9%) and 1099 patients NBP (29.9%). Patients
undergoing MBP+ABx had the lowest overall rate of
anastomotic leak (6.1%, 9.2%, 8.7% respectively) in
unadjusted analysis. After case-mix adjustment using a
mixed-effects multivariable regression model, MBP+Abx
was associated with a lower risk of anastomotic leak
(OR 0.52, 0.30–0.92, P = 0.02) but MBP was not
(OR 0.92, 0.63–1.36, P = 0.69) compared to NBP.
Conclusion This
non-randomised
study
adds
‘real-
world’, contemporaneous, and prospective evidence of
the beneficial effects of combined mechanical bowel
preparation and oral antibiotics in the prevention of
anastomotic leak following left sided colorectal resection
across diverse settings. We have also demonstrated lim-
ited uptake of this strategy in current international col-
orectal practice.
Keywords Colorectal surgery, colonic cancer, laparo-
scopic surgery, bowel preparation, anastomotic leak
What does this paper add to the literature?
This international study found that administration of
combined oral antibiotics with mechanical bowel prepa-
ration halved the odds of anastomotic leak following left
sided colorectal surgery compared to those with no
bowel preparation; a finding consistent across sensitivity
analyses. Despite this, only 16.8% of patients received
this preparation strategy in contemporary practice.
Introduction
Anastomotic leak following left sided colorectal surgery
is associated with increased morbidity and mortality,
reduced quality of life and worse oncological outcomes
[1,2]. As such, identifying perioperative measures that
may reduce anastomotic failure rates is a major research
focus.
The optimal preoperative bowel preparation regime
in left sided colorectal surgery remains controversial.
Current enhanced recovery after surgery (ERAS) recom-
mendations states that mechanical bowel preparation
(MBP) should not be used routinely in colonic surgery
due to the distressing adverse effects that can be associ-
ated [3] with lack of evidence for benefit [4,5]. The
majority of data on combined MBP with selective gas-
trointestinal
decontamination
with
oral
antibiotics
Correspondence to: Mr James Glasbey, European Society of Coloproctology
(ESCP) Cohort Studies Committee, Department of Colorectal Surgery,
University of Birmingham, Heritage Building, Mindelsohn Way, Birmingham
B15 2TH, UK.
E-mail: j.glasbey@bham.ac.uk
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
15
Original article
doi:10.1111/codi.14362
 comes from retrospective analyses of large North Ameri-
can databases. These demonstrate evidence of reduction
in anastomotic leak and surgical site infection rates
when compared to MBP alone, oral antibiotics alone or
no preparation [6–11]. Evidence from several published
clinical trials is consistent with this finding, but ran-
domised
evidence
remains
of
low
and
moderate
methodological quality with high risk of bias. In Europe
[12], mechanical bowel preparation with concurrent
oral antibiotics is the subject of a number of blinded,
multi-centre randomised trials currently open to recruit-
ment, but in the years before they report there remains
no existing high quality prospective data to support this
choice of preoperative bowel preparation strategy in
elective colectomy [13].
The primary aim of this study was to explore associ-
ations between bowel preparation strategy and anasto-
motic leak after elective left sided colorectal resection
with primary anastomosis. The secondary aims were to
explore
associations
of
anastomotic
technique
with
anastomotic failure, and to assess the clinical impact of
anastomotic leak.
Methods
Protocol
This
prospective,
observational,
multi-centre
audit
was conducted in line with a pre-specified proto-
col (http://www.escp.eu.com/research/cohort-studies).
An external pilot of the protocol and data capture sys-
tem was conducted in five international centres prior
to launch, allowing refinement of the study tool and
delivery. This data was not included within the main
study analysis.
Centre eligibility
Any unit performing gastrointestinal surgery was eligible
to register to enter patients into the study. No mini-
mum case volume, or centre-specific limitations were
applied. The study protocol was disseminated to regis-
tered members European Society of Coloproctology
(ESCP), and through national surgical or colorectal
societies.
Patient eligibility
Adult patients (> 16 years) undergoing planned, elec-
tive left hemicolectomy, sigmoid colectomy or rectal
resection
with
a
single,
primary
anastomosis
were
extracted from the main audit database. Operations
with multiple (> 1) anastomoses were excluded as were
resections with formation of end colostomy without
restoration
of
gastrointestinal
continuity
(e.g.
abdominoperineal
resection,
Hartmann’s
procedure),
more extensive colorectal resection (e.g. subtotal or
total colectomy),, pouch formation, pelvic exenteration
or multivisceral resection and reversal of colostomy.
Both malignant and benign indications for surgery were
eligible.
Open,
laparoscopic,
laparoscopic-converted,
robotic and robotic-converted procedures were all eligi-
ble, including those incorporating a perineal approach,
both traditional or transanal.
Data capture
Consecutive sampling was performed of eligible patients
over an 8-week study period in each included centres.
Local investigators commenced data collection on any
date between the 1 January 2017 and 15 March 2017,
with the last eligible patient being enrolled on 10 May
2017. This study adopted the UK National Research
Collaborative model for data collection and follow-up.
Small teams of up to five surgeons or surgical trainees
worked together to collect prospective data on all eligible
patients at each centre. Quality assurance was provided
by at least one consultant or attending-level surgeon.
Data was recorded contemporaneously and stored on a
secure, user-encrypted online platform (REDCap) with-
out using patient identifiable information. Centres were
asked to validate that all eligible patients during the study
period had been entered, and to attain > 95% complete-
ness of data field entry prior to final submission.
There were three main phases of data collection for
each
patient,
each
represented
by
separate
clinical
reporting forms. Case report form (CRF) A collected
baseline
patient-
and
disease-specific
characteristics
including Age, Gender, American Society of Anaesthesi-
ologists (ASA) classification grade, smoking history,
body mass index, history of diabetes mellitus, cardiovas-
cular disease, concurrent anticoagulant therapy, indica-
tion
for
surgery,
disease
location
and
urgency
of
surgery. CRF B collected information about the index
operation and non-patient or disease related factors
including operator grade (Consultant, Trainee), opera-
tor
specialty
interest
(Colorectal,
General
Surgery),
operative approach, level of proximal and distal transec-
tion, anastomosis type (handsewn, stapled), anastomotic
configuration
(side-to-side,
side-to-end,
end-to-end),
distance of the anastomosis from the anal verge (in cen-
timetres), whether an intraoperative leak test was per-
formed,
and
whether
a
proximal
defunctioning
enterostomy
(loop
ileostomy,
end
ileostomy,
loop
colostomy) was formed.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
16
Combined bowel prep with oral antibiotics
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
 Case report form C collected follow-up data on the
primary and secondary outcome measures. This study
was designed to bring efficiency by using normal post-
operative follow-up pathways to obtain outcome data.
Follow-up data was collected to 30 postoperative days
through review of patient notes (paper and electronic)
during their index admission, reviewing hospital systems
to check for readmission or reoperation, and reviewing
postoperative radiology reports. Where postoperative
review at or before 30 postoperative days formed part
of routine practice follow-up data was also obtained at
this clinical review.
Outcome measure
The primary outcome measure was overall anasto-
motic leak, pre-defined as either (i) gross anastomotic
leakage proven radiologically or clinically, or (ii) the
presence of an intraperitoneal (abdominal or pelvic)
fluid collection on post-operative imaging. The sec-
ondary
outcome
measures
were
the
postoperative
major complication rate, defined as Clavien-Dindo
classification grade 3 to 5 (reoperation, reintervention,
unplanned admission to critical care, organ support
requirement or death), the postoperative length of
stay (in whole days), with day of surgery as day zero,
and the postoperative mortality rate, defined as death
within 30 days of surgery.
Statistical analysis
This report has been prepared in accordance to guideli-
nes set by the STROBE (strengthening the reporting of
observational studies in epidemiology) statement for
observational studies [14].
Patient, disease and operative characteristics were com-
pared by type of bowel preparation (no bowel preparation
(NBP),
mechanical
bowel
preparation
alone
(MBP),
mechanical bowel preparation and oral antibiotics (MBP +
Abx) and by the primary outcome anastomotic leak using
Student’s t-test for normal, continuous data, Mann–Whit-
ney U test for non-normal continuous data or Chi-squared
test for categorical data. To test the association between
overall anastomotic leak and the main explanatory variables
of interest (type of bowel preparation, other non-patient
and disease related factors described above), a mixed-effects
logistic regression model was fitted. Clinically plausible
patient, disease and operation-specific factors were entered
into the model for risk-adjustment, treated as fixed effects.
These were defined a priori within the study protocol, and
included irrespective of their significance on univariate anal-
ysis. Hospitals were entered into the model as a random-
Data cleaning
Cohort selection
Records uploaded to the ESCP 
REDCap database (n=5788)
Excluded from analysis (n=147)
•  Patients <16 years (n=2)
•  Missing anastomosis type (n=49)
•  Missing anastomotic leak outcome (n= 65)
•  Missing complication outcome (n=31)
Primary restorative anastomosis formed (n=3676)
Patients undergoing elective surgery 
(n=4487)
Excluded from analysis (n=811)
•  Patients without anastomosis (n=811)
Excluded from analysis (n=1154)
•  Emergency surgery (less than 24h) (n=591)
•  Expedited surgery (less than 2 weeks)
Anastomosis type
Eligible and completed records (n=5641)
Enrollment
Included in analysis
Figure 1 Flowchart for patients included in analysis of bowel preparation and intraoperative factors in elective left colorectal
resection.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
17
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
Combined bowel prep with oral antibiotics
 Table 1 Patient and disease characteristics of patients by bowel preparation strategy.
Factor
Levels
No bowel prep
MBP only
MBP and
pre-op oral ABx
P-value
Age
< 55
254 (23.1)
371 (19.1)
115 (18.6)
0.002
55–70
451 (41.0)
887 (45.6)
265 (42.9)
70–80
296 (26.9)
516 (26.5)
170 (27.5)
> 80
98 (8.9)
171 (8.8)
65 (10.5)
Missing
0 (0.0)
0 (0.0)
3 (0.5)
Gender
Female
493 (44.9)
784 (40.3)
242 (39.2)
0.029
Male
606 (55.1)
1161 (59.7)
376 (60.8)
ASA class
Missing
0 (0.0)
5 (0.3)
24 (3.9)
< 0.001
Low risk (ASA 1–2)
828 (75.3)
1288 (66.2)
434 (70.2)
High risk (ASA 3–5)
271 (24.7)
652 (33.5)
160 (25.9)
BMI
Normal weight
361 (32.8)
552 (28.4)
193 (31.2)
< 0.001
Underweight
33 (3.0)
37 (1.9)
13 (2.1)
Overweight
443 (40.3)
837 (43.0)
262 (42.4)
Obese
241 (21.9)
497 (25.6)
113 (18.3)
Missing
21 (1.9)
22 (1.1)
37 (6.0)
History of
IHD/CVA
Missing
1 (0.1)
0 (0.0)
1 (0.2)
0.009
No
960 (87.4)
1619 (83.2)
542 (87.7)
Yes
138 (12.6)
326 (16.8)
75 (12.1)
History of diabetes
mellitus
Missing
1 (0.1)
0 (0.0)
2 (0.3)
0.038
No
969 (88.2)
1651 (84.9)
533 (86.2)
Diabetes: any
control
129 (11.7)
294 (15.1)
83 (13.4)
Smoking history
Non-smoker
893 (81.3)
1669 (85.8)
527 (85.3)
0.017
Current
200 (18.2)
260 (13.4)
84 (13.6)
Missing
6 (0.5)
16 (0.8)
7 (1.1)
Indication
Benign
335 (30.5)
321 (16.5)
124 (20.1)
< 0.001
Malignant
764 (69.5)
1624 (83.5)
494 (79.9)
Anastomosis
height
Missing
5 (0.5)
2 (0.1)
0 (0.0)
< 0.001
Left colon
159 (14.5)
175 (9.0)
76 (12.3)
Sigmoid colon
350 (31.8)
394 (20.3)
157 (25.4)
High rectum
318 (28.9)
417 (21.4)
134 (21.7)
Mid rectum
150 (13.6)
412 (21.2)
124 (20.1)
Low rectum
117 (10.6)
545 (28.0)
127 (20.6)
APER
0 (0.0)
0 (0.0)
0 (0.0)
For malignant disease (n = 2888)
Neoadjuvant therapy
Missing
11 (1.0)
5 (0.3)
4 (0.6)
< 0.001
Chemotherapy only
29 (2.6)
51 (2.6)
18 (2.9)
Long course CRTx
40 (3.6)
298 (15.3)
97 (15.7)
Short course
radiotherapy
7 (0.6)
75 (3.9)
17 (2.8)
None
674 (61.3)
1193 (61.3)
357 (57.8)
Pre-treatment
T stage
Missing
48 (4.4)
31 (1.6)
28 (4.5)
< 0.001
T1
92 (8.4)
159 (8.2)
62 (10.0)
T2
150 (13.6)
432 (22.2)
102 (16.5)
T3
359 (32.7)
806 (41.4)
226 (36.6)
T4
112 (10.2)
194 (10.0)
75 (12.1)
P-value derived from v2 test for categorical variables. % shown by column. NBP, no bowel preparation; MBP, mechanical bowel
preparation only; MBP+ABx, mechanical bowel preparation and oral antibiotics; SD, standard deviation; IQR, interquartile range;
IHD, ischemic heart disease; CVA, cerebrovascular accident; N/A, not applicable.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
18
Combined bowel prep with oral antibiotics
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
 effect, to adjust for hospital-level variation in outcome.
Sensitivity analyses were performed for proven anastomotic
leakage only. Effect estimates are presented as odds ratios
(OR) with 95% confidence intervals (95% CI) and two-
tailed P-values. An alpha level of 0.05 was used through-
out. Data analysis was undertaken using R Studio V3.1.1
(R Foundation, Boston, USA).
Ethical approval
All participating centres were responsible for compliance
to local approval requirements for ethics approval or
indemnity as required. In the UK, the National Research
Ethics Service tool recommended that this project was
not classified as research, and the protocol was registered
as clinical audit in all participating centres.
Results
Patient and disease characteristics
This analysis included 3676 patients from 343 centres
in 47 countries (Figure 1). The mean age of included
patients
was
66 years
(range
18–99 years),
58.4%
(2149/3676) were male, and the majority were low
preoperative
risk
(69.5%
ASA
1–2,
2558/3676).
Resection involved colon only in 35.8% (1317/3676)
and the rectum in 64.2% (2359/3676). The primary
indication for surgery was malignant disease in 78.7%
(2894/3676)
and
benign
disease
in
21.3%
(782/
3676). The abdominal approach was laparoscopic in
56.2%
(2065/3676),
robotic
in
3.9%
(144/3676),
and a transanal perineal approach was used in 10.0%
(369/3676).
Pre-operatively,
15.1%
(556/3676)
of
included
patients
were
on enteral
and
0.8%
(29/
3676) on parenteral nutritional supplementation. An
intra-abdominal abscess was present preoperatively in
3.0% (111/3676). Few patients were on exogenous
steroid therapy at the time of surgery (10/3676).
Amongst those with a malignant indication for sur-
gery 21.9% (634/2894) had undergone neoadjuvant
therapy,
with
long-course
chemoradiotherapy
being
most common strategy (437/634, 66.7%). The major-
ity of oncological resections were for T2 and T3
disease (686/2894, 23.7%; 1399/2894, 48.3% respec-
tively).
Practice of bowel preparation and use of preoperative
antibiotics
Overall 1099 patients received no bowel preparation
(29.9%), 1945 received MBP (52.9%) and 618 (16.8%)
received MBP+ABx. Information on type of bowel
preparation was not obtained in 14 patients. The
patient and disease characteristics of included patients,
grouped by choice of preparation strategy, is shown in
Table 1.
Compared to
those received
MBP
alone,
patients undergoing MBP+ABx were older, lower risk,
less likely to be obese, and less likely to have a history
of cardiovascular disease in comparison to those receiv-
ing NBP. When compared to those receiving NBP,
those receiving MBP+ABx were less likely to be current
smokers and were more likely to have disease involving
the low or middle rectum (Figure 2).
Figure 2 Choice of bowel preparation strategy by height of anastomosis.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
19
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
Combined bowel prep with oral antibiotics
 Table 2 Patient and disease characteristics of patients who suffered anastomotic leak.
Factor
Levels
Anastomosis
P-value
No leak
Leak
For all patients (n = 3676)
Total
3364
312
–
Age
< 55
672 (20.0)
68 (21.8)
0.499
55–70
1480 (44.0)
130 (41.7)
70–80
901 (26.8)
86 (27.6)
> 80
309 (9.2)
27 (8.7)
Missing
2 (0.1)
1 (0.3)
Gender
Female
1443 (42.9)
84 (26.9)
< 0.001
Male
1921 (57.1)
228 (73.1)
ASA class
Low risk (ASA 1–2)
2348 (69.8)
210 (67.3)
0.584
High risk (ASA 3–5)
988 (29.4)
100 (32.1)
Missing
28 (0.8)
2 (0.6)
BMI
Normal weight
1025 (30.5)
87 (27.9)
0.212
Underweight
74 (2.2)
9 (2.9)
Overweight
1416 (42.1)
128 (41.0)
Obese
781 (23.2)
76 (24.4)
Missing
68 (2.0)
12 (3.8)
History of
IHD/CVA
No
2874 (85.4)
260 (83.3)
0.073
Yes
489 (14.5)
51 (16.3)
Missing
1 (0.0)
1 (0.3)
History of diabetes mellitus
No
2898 (86.1)
268 (85.9)
0.303
Diabetes: any control
464 (13.8)
43 (13.8)
Missing
2 (0.1)
1 (0.3)
Smoking history
Non-smoker
2846 (84.6)
255 (81.7)
0.343
Current
491 (14.6)
55 (17.6)
Missing
27 (0.8)
2 (0.6)
Indication
Benign
716 (21.3)
66 (21.2)
0.957
Malignant
2648 (78.7)
246 (78.8)
Anastomosis height
Left colon
376 (11.2)
34 (10.9)
< 0.001
Sigmoid colon
842 (25.0)
65 (20.8)
High rectum
822 (24.4)
51 (16.3)
Mid rectum
635 (18.9)
52 (16.7)
Low rectum
683 (20.3)
109 (34.9)
Missing
6 (0.2)
1 (0.3)
For malignant disease (n = 2888)
Total
2643
2643
245
Neoadjuvant therapy
Chemotherapy only
92 (3.5)
6 (2.4)
0.014
Long course CRTx
388 (14.7)
49 (20.0)
Short course
radiotherapy
83 (0.1)
16 (6.5)
None
2060 (77.9)
173 (70.6)
Missing
20 (0.8)
1 (0.4)
Pre-treatment T stage
T1
293 (11.1)
20 (8.2)
0.206
T2
631 (23.9)
55 (22.4)
T3
1262 (47.7)
137 (55.9)
T4
356 (13.5)
27 (11.0)
Missing
101 (3.8)
6 (2.4)
P-value derived from v2 test for categorical variables. % shown by column. SD, standard deviation; IQR, interquartile range; IHD,
ischemic heart disease; CVA, cerebrovascular accident; N/A, not applicable.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
20
Combined bowel prep with oral antibiotics
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
 Intraoperative and technical characteristics
Attempted laparoscopy was the most common initial
operative approach (56.2%, 2065/3676), with a conver-
sion rate of 15.9% (328/2065). 39.9% (1467/3676) of
patients underwent open surgery and 3.9% (144/3676)
robotic surgery (of which 16/144, 11.1% underwent
conversion). 86.4% (3177/3676) underwent stapled
anastomosis, of which 93.7% (2977/3177) used a cir-
cular stapler. 13.6% (499/3676) of anastomoses were
handsewn.
Anastomotic leak
The overall anastomotic leak rate was 8.5% (312/3676).
Patient and disease characteristics (Table 2) and intraop-
erative and technical characteristics (Table 3) differed
between groups of patients who did and did not have
anastomotic leak. In the unadjusted analysis, patients
with leak were more likely to be male, have undergone a
low or middle rectal anastomosis, neoadjuvant therapy, a
handsewn anastomosis, a defunctioning ileostomy, or
had a planned admission to critical care from theatre.
Table 3 Intraoperative characteristics of patients who suffered anastomotic leak.
Factor
Levels
Anastomosis
P-value
No leak
Leak
Bowel preparation
NBP
1003 (29.8)
96 (30.8)
0.077
MBP
1767 (52.5)
178 (57.1)
MBP+Abx
580 (17.2)
38 (12.2)
Missing
14 (0.4)
0 (0.0)
Anastomotic configuration
End to end
2525 (75.1)
239 (76.6)
0.364
Side to side
301 (8.9)
19 (6.1)
Side to end
537 (16.0)
54 (17.3)
Missing
1 (0.0)
0 (0.0)
Anastomotic technique
Handsewn
445 (13.2)
54 (17.3)
0.044
Stapled
2919 (86.8)
258 (82.7)
Stapler Type
Circular stapler
2734 (81.3)
243 (77.9)
0.224
Linear stapler
182 (5.4)
15 (4.8)
No stapled anastomosis
445 (13.2)
54 (17.3)
Missing
3 (0.1)
0 (0.0)
Leak test performed
No
1184 (35.2)
110 (35.3)
0.689
Yes
2172 (64.6)
202 (64.7)
Missing
8 (0.2)
0 (0.0)
Defunctioning stoma
Yes
866 (25.7)
116 (37.2)
< 0.001
No
2496 (74.2)
196 (62.8)
Missing
2 (0.1)
0 (0.0)
Approach
Laparoscopic
1910 (56.8)
155 (49.7)
0.054
Open
1324 (39.4)
143 (45.8)
Robotic
130 (3.9)
14 (4.5)
Missing
0 (0.0)
0 (0.0)
Operator specialty
Colorectal
2733 (81.2)
259 (83.0)
0.662
General surgery
628 (18.7)
53 (17.0)
Missing
3 (0.1)
0 (0.0)
Operator training grade
Consultant
3097 (92.1)
292 (93.6)
0.573
Trainee
264 (7.8)
20 (6.4)
Missing
3 (0.1)
0 (0.0)
Critical care admission
None
2449 (72.8)
172 (55.1)
Planned from theatre
872 (25.9)
102 (32.7)
Unplanned from theatre
20 (0.6)
14 (4.5)
Missing
3 (0.1)
0 (0.0)
P-value derived from Chi2 test for categorical variables. % shown by column. NBP, no bowel preparation; MBP, mechanical bowel
preparation only; MBP+ABx, mechanical bowel preparation and oral antibiotics; SD, standard deviation; IQR, interquartile range;
IHD, ischemic heart disease; CVA, cerebrovascular accident; N/A, not applicable.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
21
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
Combined bowel prep with oral antibiotics
 Outcomes of patients by bowel preparation strategy
In the unadjusted analysis (Table 4), the rate of anasto-
motic leak was 6.1% (38/618) in those with MBP+ABx,
9.2% (178/1945) in those with MBP and 8.7% (96/
1099) in those with NBP. Correspondingly, the major
complication rates in those with MBP+Abx was lower
than in the other two groups (8.6%; 11.5%; 11.5%
respectively). The mean length of stay was significantly
higher in those with MBP alone (7.8 days; 8.9 days;
7.8 days respectively, P < 0.001).
In the univariate analysis, no significant association
was seen between choice of bowel preparation strategy
and anastomotic leak (Table 5). Male gender (OR 1.89,
1.37–2.62; P < 0.001) and a low rectal anastomosis
(OR 2.37, 1.19–5.42; P = 0.02) carried an increased
risk of anastomotic failure. Side-to-side configuration
(OR 0.39, 0.15–0.81; P = 0.02), stapled anastomosis
(OR 0.65, 0.44–1.01; P = 0.04), and not having a
defunctioning stoma (OR 0.56, 0.42–0.76; P < 0.001)
conveyed a statistically significant benefit.
In the multilevel model (Figure 3), MBP+Abx was
the only bowel preparation strategy associated with
lower risk of anastomotic failure (OR 0.52, 0.30–
0.92, P = 0.02) than NBP (reference). This associa-
tion was consistent in a sensitivity analysis for ‘pro-
ven’
anastomotic
leak
alone
(Table 6,
OR
0.48,
0.26–0.89, P = 0.02). Male gender remained signifi-
cantly associated with a higher rate of anastomotic
leak, and middle age and side-to-side anastomosis a
lower
rate
of
anastomotic
leak.
The
model
had
acceptable discrimination (AUC: 0.69).
Clinical impact of anastomotic leak
Patients with anastomotic leak were five times more
likely
to
die
postoperatively
than
those
without
(Table 7, 0.5% versus 3.5%, P < 0.001). Anastomotic
leak was also associated with double the postoperative
length of stay (17.2 days versus 7.9 days, P < 0.001).
The definition of anastomotic leakage chosen as the pri-
mary outcome of this study included the presence of an
intraperitoneal (abdominal or pelvic) fluid collection on
post-operative imaging as well as those leaks ‘proven’
on radiological or clinical examination. Despite giving a
rate nearly double that of the ‘proven’ leaks alone, the
impact on mortality rates and length of stay was
remarkably similar when the two groups are compared.
Discussion
This analysis of a large, multicentre prospective audit of
elective left colorectal resections demonstrated a benefit
for mechanical bowel preparation with oral antibiotics in
the reduction of anastomotic failure, which was consis-
tent across sensitivity analyses. The overall rate of usage
of this bowel preparation strategy remained low, at less
than one-fifth of the international cohort. Anastomotic
leak was associated with worse short-term survival, more
critical care usage and a prolonged length of stay.
This study adds to a growing body of evidence to
support the addition of oral antibiotics to mechanical
bowel preparation regimes for left sided colorectal sur-
gery. A comprehensive systematic review published in
2018 described six randomised controlled trials testing
MBP+ABx, failing to find a benefit upon meta-analysis
[15,16]. However, half of included studies (three of
six) were of unclear methodological quality and pub-
lished more than 20 years ago. Anastomotic outcomes
from these studies are unlikely to be comparable to
those in a modern era of minimally invasive surgery and
modernised stapling devices and thus may lack relevance
to current clinical practice. Of the more contemporary
randomised studies, all three were single-centre and of
Table 4 Outcomes of patients undergoing different types of bowel preparation strategy.
Outcome
Levels
Bowel preparation strategy
P value
NBP
MBP only
MBP+ABx
Leak
No leak
1003 (91.3)
1767 (90.8)
580 (93.9)
0.077
Leak
96 (8.7)
178 (9.2)
38 (6.1)
Post-operative complication
No major complication
973 (88.5)
1722 (88.5)
565 (91.4)
0.106
Major complication
126 (11.5)
223 (11.5)
53 (8.6)
Length of stay
Mean (SD)
7.9 (5.6)
8.9 (5.4)
7.8 (5.1)
< 0.001
Post-operative mortality
No
1091 (99.3)
1935 (99.5)
615 (99.5)
0.862
Yes
8 (0.7)
10 (0.5)
3 (0.5)
P-values derived from v2 test for categorical variables and Student’s T-test for parametric continuous variables, % shown by column.
NBP, no bowel preparation; MBP, mechanical bowel preparation only; MBP+ABx, mechanical bowel preparation and oral
antibiotics.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
22
Combined bowel prep with oral antibiotics
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
 Table 5 Univariable and multilevel models for overall anastomotic leak (primary outcome measure).
Factor
Levels
Overall anastomotic leak
OR (univariable)
OR (multilevel)
No leak
Leak
Bowel preparation
NBP
547 (25.2)
47 (23.9)
Reference
Reference
MBP
1260 (58.1)
130 (66.0)
1.20 (0.85–1.72, P = 0.303)
0.92 (0.63–1.36, P = 0.688)
MBP+ABx
360 (16.6)
20 (10.2)
0.65 (0.37–1.09, P = 0.113)
0.52 (0.30–0.92, P = 0.024)
Age
< 55
448 (20.7)
54 (27.4)
Reference
Reference
55–70
960 (44.3)
81 (41.1)
0.70 (0.49–1.01, P = 0.054)
0.64 (0.43–0.95, P = 0.025)
70–80
589 (27.2)
49 (24.9)
0.69 (0.46–1.04, P = 0.073)
0.59 (0.38–0.94, P = 0.025)
> 80
170 (7.8)
13 (6.6)
0.63 (0.32–1.16, P = 0.157)
0.61 (0.30–1.22, P = 0.159)
Gender
Female
915 (42.2)
55 (27.9)
Reference
Reference
Male
1252 (57.8)
142 (72.1)
1.89 (1.37–2.62, P < 0.001)
1.91 (1.35–2.69, P < 0.001)
ASA class
Low risk (ASA 1–2)
1536 (70.9)
137 (69.5)
Reference
Reference
High risk (ASA 3–5)
631 (29.1)
60 (30.5)
1.07 (0.77–1.46, P = 0.693)
1.04 (0.71–1.52, P = 0.834)
BMI
Normal weight
700 (32.3)
64 (32.5)
Reference
Reference
Underweight
41 (1.9)
7 (3.6)
1.87 (0.74–4.09, P = 0.146)
1.95 (0.81–4.67, P = 0.134)
Overweight
952 (43.9)
84 (42.6)
0.97 (0.69–1.36, P = 0.837)
0.94 (0.66–1.35, P = 0.741)
Obese
474 (21.9)
42 (21.3)
0.97 (0.64–1.45, P = 0.880)
0.93 (0.61–1.44, P = 0.760)
History of
IHD/CVA
No
1858 (85.7)
163 (82.7)
Reference
Reference
Yes
309 (14.3)
34 (17.3)
1.25 (0.84–1.83, P = 0.253)
1.44 (0.91–2.27, P = 0.119)
History of
diabetes mellitus
No
1874 (86.5)
170 (86.3)
Reference
Reference
Diabetes: any control
293 (13.5)
27 (13.7)
1.02 (0.65–1.53, P = 0.942)
0.97 (0.62–1.52, P = 0.883)
Smoking history
Non-smoker
1853 (85.5)
159 (80.7)
Reference
Reference
Current
314 (14.5)
38 (19.3)
1.41 (0.96–2.03, P = 0.071)
1.25 (0.84–1.85, P = 0.277)
Indication
Benign
379 (17.5)
34 (17.3)
Reference
Reference
Malignant
1788 (82.5)
163 (82.7)
1.02 (0.70–1.52, P = 0.935)
0.79 (0.51–1.23, P = 0.298)
Approach
Laparoscopic
1171 (54.0)
100 (50.8)
Reference
Reference
Open
895 (41.3)
87 (44.2)
1.14 (0.84–1.54, P = 0.398)
1.16 (0.84–1.61, P = 0.369)
Robotic
101 (4.7)
10 (5.1)
1.16 (0.55–2.19, P = 0.670)
0.86 (0.42–1.77, P = 0.680)
Anastomosis
height
Left colon
126 (5.8)
8 (4.1)
Reference
Reference
Sigmoid colon
373 (17.2)
24 (12.2)
1.01 (0.46–2.46, P = 0.975)
0.91 (0.38–2.17, P = 0.836)
High rectum
501 (23.1)
32 (16.2)
1.01 (0.47–2.39, P = 0.988)
0.91 (0.39–2.13, P = 0.827)
Mid rectum
543 (25.1)
39 (19.8)
1.13 (0.54–2.66, P = 0.758)
1.07 (0.45–2.52, P = 0.882)
Low rectum
624 (28.8)
94 (47.7)
2.37 (1.19–5.42, P = 0.023)
2.14 (0.91–5.03, P = 0.081)
Anastomotic
configuration
End to end
1594 (73.6)
150 (76.1)
Reference
Reference
Side to side
165 (7.6)
6 (3.0)
0.39 (0.15–0.81, P = 0.025)
0.38 (0.15–0.94, P = 0.036)
Side to end
408 (18.8)
41 (20.8)
1.07 (0.74–1.52, P = 0.722)
0.96 (0.65–1.42, P = 0.840)
Anastomotic
technique
Handsewn
219 (10.1)
29 (14.7)
Reference
Reference
Stapled
1948 (89.9)
168 (85.3)
0.65 (0.44–1.01, P = 0.044)
0.72 (0.44–1.18, P = 0.197)
Leak test
performed
No
733 (33.8)
73 (37.1)
Reference
Reference
Yes
1434 (66.2)
124 (62.9)
0.87 (0.64–1.18, P = 0.360)
1.04 (0.72–1.51, P = 0.832)
Defunctioning
stoma
No
1410 (65.1)
101 (51.3)
0.56 (0.42–0.76, P < 0.001)
0.96 (0.64–1.44, P = 0.841)
Yes
757 (34.9)
96 (48.7)
Reference
Reference
Operator type
Colorectal
1745 (80.5)
161 (81.7)
Reference
Reference
General surgery
422 (19.5)
36 (18.3)
0.92 (0.63–1.33, P = 0.683)
1.03 (0.68–1.56, P = 0.886)
Training grade
Consultant
2016 (93.0)
185 (93.9)
Reference
Reference
Trainee
151 (7.0)
12 (6.1)
0.87 (0.45–1.52, P = 0.642)
1.05 (0.55–1.98, P = 0.889)
AIC: 1340.3. Area Under the Receiver Operating Curve: 0.69
Overall anastomotic leak was pre-defined as either (i) gross anastomotic leakage proven radiologically or clinically, or (ii) the pres-
ence of an intraperitoneal (abdominal or pelvic) fluid collection on post-operative imaging. Odds ratio (OR) presented with 95%
confidence intervals. % shown by column. SD, standard deviation; IQR, interquartile range; IHD, ischemic heart disease; CVA,
cerebrovascular accident; N/A, not applicable.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
23
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
Combined bowel prep with oral antibiotics
 limited
methodological
rigor [17–19]. The
highest
quality of these included just 579 patients, was open-
label, and examined anastomotic leak as a secondary
outcome with no clear outcome definition or assess-
ment criteria stated.
The most convincing current evidence supporting
MBP+Abx is found in retrospective analyses of the large
American College of Surgeons’ National Surgical Qual-
ity Improvement Program (ACS-NSQUIP) database.
Seven analyses of this dataset have been published to
date, including around 147 000 patients [6–11,20].
These share common criticisms including the low fide-
lity of retrospectively collected clerical data, high per-
centages of missing data fields and a high propensity for
selection and reporting bias [6–10]. When meta-analysis
has been performed on these observational datasets a
40% reduction in odds of anastomotic leak has been
described [16].
Figure 3 Forest plot for mixed-effects model demonstrating factors associated with overall anastomotic leak.
Table 6 Univariable and multilevel models for ‘proven’ anastomotic leak only (sensitivity analysis).
Factor
Levels
Proven anastomotic leak
OR (univariable)
OR (multilevel)
No leak
Leak
Bowel preparation
NBP
554 (25.2)
40 (24.1)
Reference
Reference
MBP
1279 (58.2)
111 (66.9)
1.20 (0.83–1.77, P = 0.336)
0.94 (0.63–1.42, P = 0.780)
MBP+ABx
365 (16.6)
15 (9.0)
0.57 (0.30–1.02, P = 0.069)
0.48 (0.26–0.89, P = 0.021)
Proven anastomotic leak was defined as gross anastomotic leakage proven radiologically or clinically. Patient, disease and operative
factors included in the model are described in Table 5.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
24
Combined bowel prep with oral antibiotics
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
 This analysis represents the first prospective observa-
tional assessment of the relationship of MBP+ABx and
anastomotic leak, demonstrating a significant benefit in
elective left sided colorectal anastomoses, which pre-
vailed after risk adjustment for patient, operation and
disease factors. Few other modifiable intraoperative or
technical characteristics had a significant association
with anastomotic leak in univariate or multilevel mod-
els. Side-to-side anastomotic configuration (common in
left sided colonic, rather than rectal resections) appeared
to convey a benefit in multivariable analysis, which may
reflect other unmeasured confounders, such as technical
ease of the procedure and the number of stapler firings
in circular stapled rectal anastomoses. Whilst this study
was underpowered to detect a difference in the primary
outcome within many of these smaller subgroups, varia-
tion within our data suggests that an optimal technique
for left sided colorectal anastomosis is yet to reach con-
sensus. Whilst a number of acceptable modifications are
likely to exist, standardisation of techniques for anasto-
motic formation may improve outcomes by reducing
unacceptable variation.
The ESCP Left Sided Colorectal Resections 2017
audit used the same combined outcome measure of
radiologically or clinically ‘proven’ anastomotic leak or
intraabdominal
collection
that
has
been
previous
described in the ESCP 2015 audit of Right Sided
Resections
[21].
Again
the
data
demonstrated
an
increase in adverse postoperative events (death, length
of stay, critical care requirement) of similar magnitude
for both the combined and ‘proven’ anastomotic leak
groups, validating the use of our primary outcome mea-
sure in left sided disease. We recommend that this com-
bined outcome measure is used in future prospective
randomised and non-randomised studies.
This study presents a multicentre evaluation of bowel
preparation practice and its outcomes using a validated
‘snap-shot’
methodology
that combines
pragmatism
with
high-quality,
protocolised
data
collection
per-
formed by frontline teams of clinicians in a multicentre,
international setting [22–28]. Randomised trials are
sometimes criticised for being performed in highly
controlled settings (i.e. explanatory trials), and treat-
ment effects described are not realised when adopted
into widespread clinical practice. This study adds to the
literature by demonstrating that a signal for benefit in
combined oral antibiotics and bowel preparation is also
seen in a ‘real world’ setting. We attempted to minimise
the impact of selection bias on our findings by the
application of mixed-effects models adjusting for the
effects of patient, disease, operative and centre level
variation. However we lack the fidelity in this dataset to
examine in detail specific centre level characteristics
regarding those centres applying MBP+ABx in routine
practice (for example surgical resection volume, avail-
ability of adjuncts to testing anastomotic integrity).
There are also likely to be a number of unmeasured
patient and intraoperative risk factors for anastomotic
leak that we were unable to adjust for with this observa-
tional study.
A large, international randomised trial is needed to
determine whether antibiotics alone are sufficient, or
whether it is the combination with mechanical bowel
preparation that is mechanistic. Although the current
evidence base has been stated as being conclusive,
incomplete penetration into clinical practice as demon-
strated within this study and the relatively weak existing
data mean a major trial is warranted. Further efforts to
explore reasons for the low rate of adoption of com-
bined antibiotics and bowel preparation amongst the
international surgical community will support future
quality improvement efforts.
Acknowledgements
Supported by the European Society of Coloproctology
(ESCP).
REDCap
and
infrastructural
support
was
received from the Birmingham Surgical Trials Institute
(BiSTC)
at
the
Birmingham
Clinical
Trials
Unit
(BCTU).
Funding
None.
Table 7 The clinical impact of anastomotic leak.
Total
Length of stay (median, IQR)
30-day mortality (%, n)
No leak
3364
7 (5–9)
0.5% (18)
Anastomotic leak and/or collection*
312
15 (11–26)
3.5% (11)
‘Proven’ anastomotic leak only
166
16 (11–26)
3.6% (6)
*Primary outcome for this study – defined as either or both (i) gross anastomotic leakage proven radiologically or clinically or (ii)
the presence of an intraperitoneal (abdominal or pelvic) fluid collection on post-operative imaging. Proven anastomotic leak
included only gross anastomotic leakage proven radiologically or clinically. % shown by row. SD, standard deviation; n, count.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
25
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
Combined bowel prep with oral antibiotics
 Conflicts of interest
None to declare.
References
1 McDermott FD, Heeney A, Kelly ME, Steele RJ, Carlson
GL, Winter DC. Systematic review of preoperative, intraop-
erative and postoperative risk factors for colorectal anasto-
motic leaks. Br J Surg 2015; 102: 462–79.
2 Vallance A, Wexner S, Berho M et al. A collaborative
review of the current concepts and challenges of anasto-
motic leaks in colorectal surgery. Colorectal Dis 2017; 19:
O1–12.
3 Gustafsson UO, Scott MJ, Schwenk W et al. Guidelines for
perioperative care in elective colonic surgery: Enhanced
Recovery After Surgery (ERAS((R))) Society recommenda-
tions. World J Surg 2013; 37: 259–84.
4 Courtney DE, Kelly ME, Burke JP, Winter DC. Postopera-
tive
outcomes following
mechanical bowel
preparation
before proctectomy: a meta-analysis. Colorectal Dis 2015;
17: 862–9.
5 Guenaga KF, Matos D, Wille-Jorgensen P. Mechanical
bowel preparation for elective colorectal surgery. Cochrane
Database Syst Rev 2011: CD001544.
6 Althumairi AA, Canner JK, Pawlik TM et al. Benefits of
bowel preparation beyond surgical site infection: a retro-
spective study. Ann Surg 2016; 264: 1051–7.
7 Klinger AL, Green H, Monlezun DJ et al. The role of
bowel
preparation
in
colorectal
surgery:
results
of
the 2012-2015 ACS-NSQIP data. Ann Surg 2017; [Epub
ahead of print] https://doi.org/10.1097/sla.0000000000
002568
8 Koller SE, Bauer KW, Egleston BL et al. Comparative
effectiveness and risks of bowel preparation before elective
colorectal surgery. Ann Surg 2018; 267: 734–42.
9 Midura EF, Jung AD, Hanseman DJ et al. Combination
oral and mechanical bowel preparations decreases complica-
tions in both right and left colectomy. Surgery 2018; 163:
528–34.
10 Moghadamyeghaneh Z, Hanna MH, Carmichael JC et al.
Nationwide analysis of outcomes of bowel preparation in
colon surgery. J Am Coll Surg 2015; 220: 912–20.
11 Scarborough JE, Mantyh CR, Sun Z, Migaly J. Combined
mechanical and oral antibiotic bowel preparation reduces
incisional surgical site infection and anastomotic leak rates
after elective colorectal resection: an analysis of colectomy-
targeted ACS NSQIP. Ann Surg 2015; 262: 331–7.
12 Chen M, Song X, Chen LZ, Lin ZD, Zhang XL. Compar-
ing mechanical bowel preparation with both oral and sys-
temic antibiotics versus mechanical bowel preparation and
systemic antibiotics alone for the prevention of surgical site
infection after elective colorectal surgery: a meta-analysis of
randomized controlled clinical trials. Dis Colon Rectum
2016; 59: 70–8.
13 Clinicaltrials.gov
(2018).
Mechanical
Bowel
Preparation
and Oral Antibiotics Before Colon Cancer Surgery – Full
Text View – ClinicalTrials.gov. https://clinicaltrials.gov/
ct2/show/NCT03475680 (accessed May 2018).
14 von Elm E, Altman DG, Egger M et al. Strengthening the
Reporting
of
Observational
Studies
in
Epidemiology
(STROBE) statement: guidelines for reporting observa-
tional studies. BMJ 2007; 335: 806–8.
15 Kaslow SR, Gani F, Alshaikh HN, Canner JK. Clinical out-
comes following mechanical plus oral antibiotic bowel
preparation versus oral antibiotics alone in patients under-
going colorectal surgery. BJS Open 2018; 2: 238–45.
16 McSorley ST, Steele CW, McMahon AJ. Meta-analysis of
oral antibiotics, in combination with preoperative intra-
venous antibiotics and mechanical bowel preparation the
day before surgery, compared with intravenous antibiotics
and mechanical bowel preparation alone to reduce surgical-
site infections in elective colorectal surgery. BJS Open
2018; 2: 185–94.
17 Lewis RT. Oral versus systemic antibiotic prophylaxis in
elective colon surgery: a randomized study and meta-analy-
sis send a message from the 1990s. Can J Surg 2002; 45:
173–80.
18 Hata H, Yamaguchi T, Hasegawa S et al. Oral and par-
enteral versus parenteral antibiotic prophylaxis in elective
laparoscopic colorectal surgery (JMTO PREV 07-01): a
phase 3, multicenter, open-label, randomized trial. Ann
Surg 2016; 263: 1085–91.
19 Sadahiro S, Suzuki T, Tanaka A et al. Comparison between
oral antibiotics and probiotics as bowel preparation for
elective colon cancer surgery to prevent infection: prospec-
tive randomized trial. Surgery 2014; 155: 493–503.
20 Kiran RP, Murray AC, Chiuzan C, Estrada D, Forde K.
Combined preoperative mechanical bowel preparation with
oral antibiotics significantly reduces surgical site infection,
anastomotic leak, and ileus after colorectal surgery. Ann
Surg 2015; 262: 416–25; discussion 23-5.
21 European
Society
of
Coloproctology.
The
relationship
between method of anastomosis and anastomotic failure
after right hemicolectomy and ileo-caecal resection: an inter-
national snapshot audit. Colorectal Dis 2017; 19: e296–311.
22 STARSurg Collaborative. Impact of postoperative non-ster-
oidal anti-inflammatory drugs on adverse events after gas-
trointestinal surgery. Br J Surg 2014; 101: 1413–23.
23 Outcomes After Kidney injury in Surgery (OAKS): protocol
for a multicentre, observational cohort study of acute kid-
ney injury following major gastrointestinal and liver sur-
gery. BMJ Open 2016; 6: e009812.
24 STARSurg Collaborative. Multicentre prospective cohort
study of body mass index and postoperative complications
following gastrointestinal surgery. Br J Surg 2016; 103:
1157–72.
25 GlobalSurg Collaborative. Mortality of emergency abdomi-
nal surgery in high-, middle- and low-income countries. Br
J Surg 2016; 103: 971–88.
26 GlobalSurg Collaborative. Surgical site infection after gas-
trointestinal surgery in high-income, middle-income, and
low-income countries: a prospective, international, multi-
centre cohort study. Lancet Infect Dis 2018; 18: 516–25.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
26
Combined bowel prep with oral antibiotics
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
 27 West Midlands Research Collaborative. Right Iliac Fossa
Pain Treatment (RIFT) Study: protocol for an interna-
tional, multicentre, prospective observational study. BMJ
Open 2018; 8: e017574.
28 Chapman SJ, EuroSurg Collaborative. Ileus Management
International
(IMAGINE):
protocol
for
a
multicentre,
observational study of ileus after colorectal surgery. Colorec-
tal Dis 2018; 20: O17–25.
Authorship list (PubMed Citable)
Writing group
James C Glasbey (Chair), Ruth Blanco-Colino, Michael
Kelly, Baljit Singh, Dmitri Nepogodiev, Aneel Bhangu,
Thomas Pinkney, Tomas Poskus.
ESCP cohort studies and audits committee
Alaa El-Hussuna (2017 Audit Lead), Nick J. Battersby,
Aneel Bhangu, Nicolas C. Buchs, Christianne Buskens,
Sanjay Chaudri, Matteo Frasson, Gaetano Gallo, James
Glasbey, Ana Mar�
ıa Minaya-Bravo, Dion Morton, Ionut
Negoi, Dmitri Nepogodiev, Francesco Pata, Tomas
Poskus,
Luis
S�
anchez-Guill�
en,
Baljit
Singh,
Oded
Zmora, Thomas Pinkney (Chair)
Statistical analysis and data management
James Glasbey, Dmitri Nepogodiev, Rita Perry, Laura
Magill, Aneel Bhangu (Guarantor)
ESCP research committee
Dion
Morton
(Chair),
Donato
Altomare,
Willem
Bemelman, Steven Brown, Christianne Buskens, Quen-
tin Denost, Charles Knowles, Søren Laurberg, J�
er�
emie
H. Lefevre, Gabriela M€
oeslein, Tom Pinkney, Caro-
lynne Vaizey, Oded Zmora
Collaborators
Albania: S. Bilali, V. Bilali (University Hospital Center
Mother Teresa).
Argentina: M. Salomon, M. Cillo, D. Estefania, J.
Patron Uriburu, H. Ruiz (Buenos Aires British Hospi-
tal); P. Farina, F. Carballo, S. Guckenheimer (Hospital
Pirovano).
Australia: D. Proud, R. Brouwer, A. Bui, B. Nguyen,
P. Smart (Austin Hospital); A. Warwick, J. E. Theodore
(Redcliffe Hospital).
Austria: F. Herbst, T. Birsan, B. Dauser, S. Ghaffari,
N. Hartig (Barmherzige Brueder, Wien); A. Stift, S.
Argeny, L. Unger (Medical University of Vienna); R.
Strouhal, A. Heuberger (Oberndorf b. Salzburg).
Belarus: A. Varabei, N. Lahodzich, A. Makhmudov,
L. Selniahina (Minsk Regional Clinical Hospital).
Belgium: T. Feryn, T. Leupe, L. Maes, E. Reynvoet,
K. Van Langenhove (AZ Sint-Jan Brugge); M. Nachter-
gaele (AZ St Jozef); B. Monami, D. Francart, C. Jehaes,
S. Markiewicz, J. Weerts (Clinique St Joseph, Liege); K.
Van Belle, B. Bomans, V. Cavenaile, Y. Nijs, M. Ver-
truyen (Europe Hospitals Brussels); P. Pletinckx, D.
Claeys, B. Defoort, F. Muysoms, S. Van Cleven (Maria
Middelares Gent); C. Lange, K. Vindevoghel (OLV van
Lourdes Hospital Waregem); A. Wolthuis (University
Hospital Leuven).
Bosnia and Heregovina: M. Todorovic, S. Dabic, B.
Kenjic,
S.
Lovric,
J.
Vidovic
(JZU
Hospital
Sveti
Vra�
cevi); S. Delibegovic, Z. Mehmedovic (University
Clinic Center Tuzla).
Brazil: A. Christiano, B. Lombardi, M. Marchiori Jr,
V. Tercioti Jr (Hospital Centro M�
edico de Campinas).
Bulgaria: D. Dardanov, P. Petkov, L. Simonova, A.
Yonkov, E. Zhivkov (Alexandrovska Hospital - First
Surgery); S. Maslyankov, V. Pavlov, M. Sokolov, G.
Todorov
(Alexandrovska
Hospital,
Second
Surgery
Clinic); V. Stoyanov, I. Batashki, N. Iarumov, I. Lozev,
B. Moshev (Medical Institute - Ministry of Interior);
M. Slavchev, B. Atanasov, N. Belev, P. Krstev, R. Pen-
kov (University Hospital - Eurohospital).
Croatia: G. �
Santak, J. �
Cosi�
c, A. Previ�
si�
c, L. Vuku�
si�
c,
G. Zukanovi�
c (County Hospital Po�
zega); M. Zeli�
c, D.
Kr�
sul, V. Leki�
c Vitlov, D. Mendrila (University Hospital
Rijeka).
Czech Republic: J. Orhalmi, T. Dusek, O. Maly, J.
Paral, O. Sotona (Charles University Hospital). M.
Skrovina, V. Bencurik, M. Machackova (Complex Oncol-
ogy Centrer Novy Jicin, Surgical Department); Z. Kala,
M. Farka�
sov�
a, T. Grolich, V. Proch�
azka (Surgical Depart-
ment, University Hospital Brno); J. Hoch, P. Kocian, L.
Martinek (University Hospital Motol, Prague); F. Antos,
V. Pruchova (University Hospital Prague Bulovka).
Denmark: A. El-Hussuna, A. Ceccotti, T. Madsbøll,
D. Straarup, A. Uth Ovesen (Aalborg University Hospi-
tal); P. Christensen, P. Bondeven, P. Edling, H. Elfeki,
V. Alexandrovich Gameza, S. Michelsen Bach, I. Zhelti-
akova (Aarhus University Hospital/Randers Regional
Hospital); PM. Krarup, A. Krogh, H-C. Rolff (Bispeb-
jerg); J. Lykke, A. F. Juvik, H. H. K. L�
oven, M. Marck-
mann, J. T. F. Osterkamp (Herlev Hospital); A. H.
Madsen, J. Worsøe (Hospital Unit West); A. Ugianskis
(North Denmark Regional Hospital); M. D. Kjær, B.
Youn Cho Lee (Odense University Hospital); A. Khalid,
M. H. Kristensen (Regional Hospital Viborg).
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
27
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
Combined bowel prep with oral antibiotics
 Egypt: M. El Sorogy, A. Elgeidie, M. Elhemaly, A.
El Nakeeb, M. Elrefai (Gastrointestinal Surgery Center,
Mansoura University); M. Shalaby, S. Emile, W. Omar,
A. Sakr, W. Thabet (Mansoura University Hospital); S.
Awny, I. Metwally, B. Refky, N. Shams, M. Zuhdy
(Oncology Center Mansoura University).
Finland: A. Lepist€
o, I. Ker€
anen, A. Kivel€
a, T. Lehto-
nen, P. Siironen (Helsinki University Hospital); T. Rau-
tio, M. Ahonen-Siirtola, K. Klintrup, K. Paarnio, H.
Takala (Oulu University Hospital); M. Hy€
oty, E. Hauk-
ij€
arvi, S-M. Kotaluoto, K. Lehto, T. Tomminen (Tam-
pere University Hospital); H. Huhtinen, A. Carpelan, J.
Karvonen, A. Rantala, P. Varpe (Turku University
Hospital).
France: E. Cotte, Y. Francois, O. Glehen, G. Passot
(Centre Hospitalier Lyon Sud); A. d’Alessandro, E.
Chouillard, J. C. Etienne, E. Ghilles, B. Vinson-Bonnet
(Centre Hospitalier Poissy Saint Germain en Laye); A.
Germain, A. Ayav, L. Bresler (CHU Nancy-Brabois); R.
Chevalier, Q. Denost, R. Didailler, E. Rullier (Hopital
Haut Leveque); E. Tiret, N. Chafai, J. H. Lefevre, Y.
Parc (H^
opital Saint-Antoine); I. Sielezneff, D. Mege
(Timone Hospital); Z. Lakkis (University Hospital of
Besancon); M. Barussaud (University Hospital of Poi-
tiers).
Germany: C. Krones, B. Bock, R. Webler (Marien-
hospital Aachen); J. Baral, T. Lang, S. M€
unch, F. Pul-
lig, M. Sch€
on (St€
adtisches Klinikum Karlsruhe); S.
Hinz, T. Becker, T. M€
oller, F. Richter, C. Schafmayer
(University Hospital Schleswig-Holstein, Kiel); J. Hardt,
P. Kienle (University Medical Center Mannheim); F.
Crescenti, M. Ahmad, Y. Soleiman (Verden KRH).
Greece: I. Papaconstantinou , A. Gklavas, K. Nastos,
T. Theodosopoulos, A. Vezakis (Areteion Hospital); K.
Stamou, A. Saridaki (Athens Bioclinic); E. Xynos, S.
Paraskakis, N. Zervakis (Creta-InterClinic Hospital); G.
Skroubis, T. Amanatidis, S. Germanos, I. Maroulis, G.
Papadopoulos (General University Hospital of Patras);
N. Dimitriou, A. Alexandrou, E. Felekouras, J. Griniat-
sos, I. Karavokyros (Laiko Hospital); A. Papadopoulos,
C. Chouliaras, P. Ioannidis, D. Katsounis, E. Kefalou
(Nikaia General Hospital); I. E. Katsoulis, D. Balalis, D.
P. Korkolis, D. Manatakis (St. Savvas Cancer Hospital);
G. Tzovaras, I. Baloyiannis, I. Mamaloudis (University
Hospital of Larissa).
Hungary:
G.
L�
az�
ar,
S.
�
Abraham,
A.
Paszt,
Z.
Simonka, I. T�
oth (Department of Surgery, University of
Szeged);
A.
Zar�
and,
Z.
Baranyai,
G.
Ferreira,
L.
Hars�
anyi, P. �
Onody (Semmelweis University, 1st Clinic
of Surgery); B. Banky,
�
A. Bur�
any, M. Lakatos, J.
Marton,
A.
Solymosi
(St.
Borbala
Hospital);
I.
Beszny�
ak, A. Bursics, G. Papp, G. Saftics, I. Svastics
(Uzsoki Hospital);
Iceland: E. Valsdottir, J. Atladottir, T. Jonsson, P.
Moller, H. Sigurdsson (University Hospital of Iceland).
India: S. K. Gupta, S. Gupta, N. Kaul, S. Mohan, G.
Sharma (Government Medical College, Jammu, Jammu
and Kashmir, India); R. Wani, N. Chowdri, M. Khan,
A. Mehraj, F. Q. Parray (Sher-i-Kashmir Institute of
Medical Sciences).
Ireland: A. Coveney, J. Burke, J. Deasy, S. El-Masry,
D. McNamara (Beaumont Hospital); M. F. Khan, R.
Cahill, E. Faul, J. Mulsow, C. Shields (Mater Misericor-
diae University Hospital); D. Winter, R. Kennelly, A.
Hanly, M. Ismaiel, S. Martin, D. Ahern, M. Kelly, G.
Bass, R. O’Connell (St. Vincent’s University Hospital,
Dublin); T. Connelly, G. Ahmad, W. Bukhari, F. Cooke
(University Hospital Waterford).
Israel: O. Zmora, R. Gold Deutch, N. Haim, R.
Lavy, A. Moscovici (Assaf Harofe Medical Center); N.
Shussman, R. Gefen, G. Marom, A. Pikarsky, D. Weiss
(Hadassah Hebrew University Medical Center); S. Avi-
tal, N. Hermann, B. Raguan, M. Slavin, I. White (Meir
Medical Center); N. Wasserberg, H. Arieli, N. Gurevich
(RMC, Beilinson Campus); M. R. Freund, S. Dorot, Y.
Edden, G. Halfteck, P. Reissman (Shaare Zedek Medi-
cal Center); Y. Edden, R. Pery (Sheba Medical Center);
H. Tulchinsky, A. Weizman (Sourasky Medical Center).
Italy: F. Agresta, R. Curinga, E. Finotti, G. Savino,
L. A. Verza (Adria Hospital); C. R. Asteria, L. Boccia,
A. Pascariello (ASST - Mantua); N. Tamini, A. Bugatti,
L. Gianotti, M. Totis (Asst-Monza, Ospedale San Ger-
ardo); L. Vincenti, V. Andriola, I. Giannini, E. Trava-
glio
(Azienda
Ospedaliero
Universitaria
Consorziale
Policlinico di Bari); R. Balestri, P. Buccianti, N. Roffi,
E. Rossi, L. Urbani (Azienda Ospedaliero Universitaria
Pisana); A. Mellano, A. Cinquegrana (Candiolo Cancer
Institute IRCCS); A. Lauretta, C. Belluco (Chirurgia
Oncologica Generale, IRCCS Centro di Riferimento
Oncologico, Aviano); M. Mistrangelo, M. E. Allaix, S.
Arolfo, M. Morino, V. Testa (Citta della Salute e della
Scienza di Torino); P. Delrio, U. Pace, D. Rega, D.
Scala (Division of Colorectal Surgery, Department of
Abdominal Surgery, Istituto Nazionale Tumori “Fon-
dazione G.Pascale “, IRCCS Naples); G. Gallo, G. Cler-
ico,
S.
Cornaglia,
A.
Realis
Luc,
M.
Trompetto
(Department of Colorectal Surgery, S. Rita Clinic); G.
Ugolini, N. Antonacci, S. Fabbri, I. Montroni, D. Zat-
toni (Faenza Hospital); C. D’Urbano, A. Cornelli, M.
Viti (G. Salvini); M. Inama, M. Bacchion, A. Casaril, H.
Impellizzeri, G. Moretto (Hospital Dott. Pederzoli); A.
Spinelli, M. Carvello, G. David, F. Di Candido, M. Sac-
chi (Humanitas Research Hospital); A. Frontali, V.
Ceriani, M. Molteni (IRCCS MultiMedica); R. Rosati,
F. Aleotti, U. Elmore, M. Lemma, A. Vignali (IRCCS
San Raffaele, Department of Gastrointestinal Surgery);
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
28
Combined bowel prep with oral antibiotics
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
 S. Scabini, G. Casoni Pattacini, A. Luzzi, E. Romairone
(Policlinico San Martino, Genoa); F. Marino, D. Lor-
usso, F. Pezzolla (Dept. of General Surgery, IRCCS
“Saverio
de
Bellis”,
Castellana
Grotte
(Ba));
F.
Colombo, C. Baldi, D. Foschi, G. Sampietro, L. Sor-
rentino (L. Sacco University Hospital); S. Di Saverio, A.
Birindelli, E. Segalini, D. Spacca (Maggiore Hospital);
G. M. Romano, A. Belli, F. Bianco, S. De franciscis, A.
Falato (Surgical Oncology Istituto Nazionale Tumori
G.Pascale Naples); A. Muratore, P. Marsanic (Ospedale
Agnelli Pinerolo); S. Grimaldi, N. Castaldo, M. G.
Ciolli, P. Picarella, R. Porfidia (Ospedale Convenzion-
ato Villa dei Fiori Acerra); S. Di Saverio, A. Birindelli,
G. Tugnoli (Ospedale Maggiore); A. Bondurri, D.
Cavallo, A. Maffioli, A. Pertusati (Ospedale Sacco Italy);
F. Pulighe, F. Balestra, C. De Nisco, M. Podda (Ospe-
dale San Francesco); E. Opocher, M. Longhi, N. M.
Mariani, N. Maroni, A. Pisani Ceretti (Ospedale San
Paolo); R. Galleano, P. Aonzo, G. Curletti, L. Reggiani
(Ospedale Santa Corona); M. Marconi, L. Del Prete,
M. Oldani, R. Pappalardo, S. Zaccone l (Ospedale Santa
Maria delle Stelle); M. Scatizzi, M. Baraghini, S. Canta-
fio, F. Feroci, I. Giani (Ospedale Santo Stefano, Prato);
R. Tutino, G. Cocorullo, G. Gulotta, L. Licari, G. Sala-
mone (Policlinico ‘P. Giaccone’); P. Sileri, F. Saraceno
(Policlinico Tor Vergata); F. La Torre, P. Chirletti, D.
Coletta, G. De Toma, A. Mingoli (Policlinico Umberto
I ‘Sapienza University’); M. Papandrea, E. De Luca, R.
Sacco, G. Sammarco, G. Vescio (Policlinico Universi-
tario di Catanzaro); V. Tonini, S. Bianchini, M. Cervel-
lera, S. Vaccari (Policlinico universitario Sant’Orsola-
Malpighi,
Universita
degli
Studi
di
Bologna);
N.
Cracco, G. Barugola, E. Bertocchi, R. Rossini, G. Ruffo
(Sacro Cuore Don Calabria Hospital); A. Sartori, N.
Clemente, M. De Luca, A. De Luca, G. Scaffidi (San
Valentino Hospital); L. Lorenzon, G. Balducci, T. Boc-
chetti, M. Ferri, P. Mercantini (Sant’Andrea Hospital);
F. Pata, S. Bauce, A. Benevento, C. Bottini, P. R. Crapa
(Sant’ Antonio Abate Hospital, Gallarate); M. Rubbini,
G.
Anania,
P.
Carcoforo,
G.
Cavallesco,
C.
Feo
(University Hospital of Ferrara).
Japan: T. Yamamoto (Yokkaichi Hazu Medical Cen-
tre).
Latvia: A. Sivins, G. Ancans, S. Gerkis, R. Lunis, A.
Pcolkins (Latvia Oncology Center).
Lithuania: D. Venskutonis, S. Bradulskis, E. Dainius,
A. Subocius, J. Vencius (Deparment of General Surgery,
LSMU, Kaunas Clinical Hospital); P. Zeromskas, V.
Eismontas, V. Nutautiene, D. Simcikas, A. Tamosiunas
(Klaipeda University Hospital); S. Svagzdys, T. Latkaus-
kas, P. Lizdenis, Z. Saladzinskas, A. Tamelis (Lithuanian
University of Health Sciences Hospital Kauno Klinikos);
A. Dulskas, J. Kuliavas, N. E. Samalavicius (National
Cancer Institute, Lithuania); T. Poskus, V. Jotautas, S.
Mikalauskas, E. Poskus, K. Strupas (Vilnius University).
Malaysia: A. D. Zakaria, N. N.Lah, M. Wong, W. Z.
Zain, Z. Zakaria (Department of Surgery, School of
Medical Sciences, Universiti Sains Malaysia / Hospital
Universiti Sains Malaysia); L. Mazlan, Z. A. Mohd
Azman, I. Sagap (UKM Medical Centre).
Malta: J. Psaila, P. Andrejevic, C. Cini, S. Ellul, K.
Pace (Mater Dei Hospital). Morocco: M. Ahallat, M.
Hamid, A. Hrora, M. A. Majbar, M. Raiss (Ibn Sina
University Hospital).
Netherlands: E. Westerduin, W. Bemelman, C. Bus-
kens, P. Tanis (Academic Medical Centre); P.C. van der
Sluis, P.H. Davids, A. Pronk, A.H.W. Schiphorst, N.
Smakman
(Diakonessenhuis);
D.
Zimmerman,
T.
Koeter, J. Stijns, Y-T. van Loon (Elisabeth TweeSteden
Hospital); M. Vermaas, E. de Graaf, P. Doornebosch,
P. van Hagen, O. van Ruler (Ijsselland Ziekenhuis); B.
Toorenvliet, J. Nonner, I. van den Berg, L. van Steen-
sel, W. Vles (Ikazia); J. Melenhorst, R. Orsini, R. Viss-
chers (Maastricht University Medical Centre); C. Hoff
(Medical Center Leeuwarden); R. Blom, H. Marsman
(Onze Lieve Vrouwe Gasthuis); I. Mulder, H. Cense, S.
de Castro, A. Demirkiran, M. Hunfeld (Rode Kruis
Ziekenhuis Beverwijk); A. van Geloven, J. de Groof, E.
Hendriks, M. Leeuwenburg, N. van Oorschot (Ter-
gooi); F. Wit, C. Rupert, P. Veldman (Tjongerschans
ziekenhuis); M. Keijzers, J. Konsten (VieCuri Medisch
Centrum voor Noord Limburg); F. Den Boer, M. Cor-
ver (Zaans Medical Center); E. G.. Boerma, L. Koolen,
M. Martens, K. Van Wijck (Zuyderland Medical Cen-
ter).
Norway: D. Ignjatovic, R. Breuer, B. Gurpreet, T.
Oresland, T. Tetens Moe (Akershus University Hospi-
tal); A. Nesbakken, I. Flaaten Backe, T-A. Wik (Oslo
University Hospital); K. Radiya, T. Dehli, P. Gjessing,
S. Norderval, K. Woll (University Hospital of North
Norway).
Pakistan: M. Anwer, M. S. Qureshi (JPMC WARD
2); A. U. Qureshi, M. Billah, M. Y. Jawad, A. Raza, N.
Urooj (King Edward Medical University/Mayo Hospi-
tal, Lahore).
People’s Republic of China: X. Wang, L. Li (West
China Hospital in Sichuan University).
Poland: D. Jajtner, B. Gasinski, W. Kabiesz (Beskid-
ian Oncology Center); P. Walega, M. Romaniszyn
(Third Department of General Surgery, Jagiellonian
University Medical College); M. Zawadzki, R. Czar-
necki, Z. Obuszko, M. Rzaca, M. Sitarska (Wojew�
odzki
Szpital Specjalistyczny).
Portugal: P. Silva, A. Duarte, D. Gonc
�alves, M.
Morais (Centro Hospitalar de S. Jo~
ao); N. Rama, J.
Nobre, I. Sales (Centro Hospitalar Leiria, EPE); J.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
29
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
Combined bowel prep with oral antibiotics
 Costa Pereira, S. Costa, C. Costa Pereira, C. Insua, I.
Romero (Centro Hospitalar T^
amega e Sousa); N. Fig-
ueiredo, J. Cunha, H. Domingos, P. Vieira (Champali-
maud
Foundation);
M.
Cunha,
M.
Americano,
E.
Amorim, J. Rachadell (Cirurgia 2 - CHA - Unidade
Portim~
ao); J. M. Carvas, I. Armas, P. Fernandes, C.
Pires, R. Reis (Hospital de Braganc
�a); R. Martins, M.
Dos Santos, P. Henriques (Hospital de Faro, Centro
Hospitalar do Algarve); O. Oliveira, M. Duarte, L. Fer-
reira, J. Miranda, N. Vilela (Hospital Distrital de San-
tar�
em, E.P.E.); J. Corte Real, S. Carlos, M. Frois
Borges, P. Moniz Pereira, J. Sim~
oes (Hospital Garcia de
Orta); P. Silva-vaz, V. Bettencourt, A. Gouveia, H.
Perez, R. Rainho (Unidade Local de Sa�
ude de Castelo
Branco).
Romania: V. Bintintan, C. Ciuce, G. Dindelegan, R.
Scurtu, R. Seicean (Clinica Chirurgie I); D. Cristian, T.
Burcos, F. Grama, D. M. Mandi, G. Richiteanu (Coltea
Clinical Hospital); A. Miron, V. Calu, O. Enciu, M.
Nadragea, R. Parvuletu (Elias Emergency Hospital); S.
S. Mogoanta, A. Crafciuc, S. Paitici (Emergency County
Hospital of Craiova); I. Negoi, M. Beuran, C. Ciubo-
taru, A. Prodan, M. Vartic (Emergency Hospital of
Bucharest); V. Tomulescu, C. Copaescu (Ponderas Aca-
demic Hospital).
Russia: A. Yanishev, A. Abelevich, A. Kokobelyan,
M. Lebedeva, R. Luzan (FSBEI HE PRMU MOH); A.
Pozdnyakov, D. Cherdancev, D. Mahotin, A. Nesytykh,
V. Samsonyuk (Krasnoyarsk Regional Clinical Hospital);
I. Pravosudov, D. Ivlev, A. Karachun, K. Lebedev, D.
Samsonov (N.N. Petrov National Medical Research
Center of Oncology); R. Aiupov, D. Feoktistov, M.
Garipov,
N.
Suleymanov,
N.
Tarasov
(Republican
Oncological Centre, Ufa); A. Rasulov, H. Dzhumabaev,
Z. Mamedli (Russian Cancer Research Center); A. Bed-
zhanyan (Russian Research Center of Surgery named
after B.V.Petrovsky); D. Popov, A. Sednev, A. Kli-
menko, A. Semenov, S. Vasilyev (Saint-Petersburg City
Hospital 9); A. Khazov, M. Khanevich, G. Khrykov
(Saint-Petersburg Clinical Oncological Health Center);
S. Katorkin, P. Andreev, A. Chernov, O. Davidova, A.
Zhuravlev (Samara State Medical University); S. Achka-
sov, D. Shakhmatov, Y. Shelygin, O. Sushkov, A. Var-
danyan (State Scientific Centre of Coloproctology); A.
Ilkanich, N. Barbashinov, V. Darvin, S. Onishchenko,
Y. Voronin (Surgut District Hospital).
Serbia: Z. Krivokapi�
c, G. Bari�
si�
c, I. Dimitrijevi�
c, V.
Markovi�
c, A. Sekuli�
c (Clinic for Digestive Surgery-First
Surgical Clinic, Clinical Center of Serbia, University of
Belgrade, Medical Faculty); G. Stanojevic, B. Brankovic,
M. Nestorovic, V. Pecic, D. Petrovic (Clinic for General
Surgery, Clinical Center Nis); I. Kostic, A. Aleksic, D.
Dabic, B. Maric, V. Perunicic (General Hospital Cacak);
Z. Radovanovic, M. Djuric, D. Lukic, D. Radovanovic
(Oncology Institute of Vojvodina); V. Cuk, V. Cuk, J.
Juloski, M. Kenic, I. Krdzic (Surgical Clinic KBC Zvez-
dara).
Singapore: J. C. Ngu, Y. Y. Ng, N. Teo (Changi
General Hospital).
Slovak Republic: J. Korcek, A. Lazorisak, (Faculty
Hospital Nitra).
Slovenia: M. Rems, �
S. Ramov�
s Trampu�
s (General
Hospital Jesenice); A. Tomazic, J. Grosek, J. Kosir, G.
Norcic (University Medical Centre Ljubljana).
Spain: V. Vigorita, N. Caceres, E. Casal, A. Ruano,
I. Trostchansky (Alvaro Cunqueiro Hospital); T. Golda,
A. Galvez Salda~
na, E. Kreisler Moreno, J. Lopez Dom-
inguez, M. Vila Tura (Bellvitge University Hospital); F.
Labarga, P. Galvez, V. Maderuelo, C. Suero (Complejo
Asistencial Universitario de Palencia); J. Bargallo, L.
Cayetano, S. Lamas, M. C. Silva (Consorci Sanitari de
Terrassa - Hospital de Terrassa); J. C. Bernal-Sprekel-
sen, R. G�
omez, S. Jare~
no, A. R�
ıos, D. Vercher (Consor-
cio
Hospital
General
Universitario);
J-M.
Garc�
ıa-
Gonz�
alez, J. Cervera-Aldama, J. Ramos-Prada, M. San-
tamar�
ıa-Olabarrieta (Cruces University Hospital); N.
Borda, J. M. Enrriquez-Navascu�
es, Y. Saralegui (Donos-
tia Universitary Hospital); A. Calero-Lillo, S. Aznar-
Puig, M. A. L�
opez-Lara, S. Mu~
noz-Collado, J. Val-
verde-Sintas
(Fundacio
Hospital
Esperit
Sant);
P.
Menendez, C. Leon (Gutierrez Ortega Hospital); N.
Truan, R. Baldonedo, D. Fern�
andez-Mart�
ınez, J. Otero,
L.
Solar-Garc�
ıa
(Hospital
Universitario
Central
de
Asturias); V. Turrado-Rodriguez, F. de Lacy Oliver, A.
M. Lacy Fortuny, B. Martin Perez, A. M. Otero Pi~
neiro
(Hospital Clinic Barcelona); J. Paredes, F. Fernandez,
M. J. Ladra, A. Paulos, D. Prieto (Hospital Clinico
Universitario de Santiago de Compostela); J. P. Beltr�
an
de Heredia, F. Blanco Antona, B. de Andr�
es Asenjo, C.
Ferreras Garc�
ıa, A. Romero de Diego (Hospital Cl�
ınico
Universitario
de
Valladolid);
E.
Cordoba
Diaz
de
Laspra, E. Echazarreta Gallego, M. Elia Guedea (Hospi-
tal Clinico Universitario de Zaragoza); D. Escola, S.
Martinez (Hospital Comarcal Alt Penedes); V. Primo
Romaguera, R. Parre~
no, L. Pastor, E. Rosell (Hospital
de D�
enia); R. Lozoya Trujillo, R. Al�
os Company, M.
D. Ruiz Carmona, A. Solana Bueno (Hospital de
Sagunto); S. Salvans Ruiz, S. Alonso Gonc
�alves, M.
Jim�
enez-
Toscano,
M.
Pascual
Damieta,
M.
Pera
Roman (Hospital Del Mar); E. M. Pellicer-Franco, J. A.
Garcia-Marin, M. Mengual-Ballester, V. Soria-Aledo, G.
Valero-Navarro (Hospital Morales Meseguer); M. Vice-
nte-Ruiz, C. Garcia-Zamora, A. Gonzalez-Gil, M. J.
Montoya-Tabares, M. Paredes-Quiles (Hospital Rafael
Mendez); J. Die Trill, P. Abadia, I. Moreno, J. D. Pina,
D. Ramos Rubio (Hospital Ramon y Cajal); J. Escartin,
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
30
Combined bowel prep with oral antibiotics
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
 J. L. Blas, J. Fernando, R. Ferrer, J. Garcia Egea
(Hospital Royo Villanova); I. Pros, W. Martinez, J.
Rius, M. Soc�
ıas (Hospital Sant Joan de Deu de Mar-
torell); D. Sabia, J. Castellvi Valls, V. Gonzalez Santin,
S. Mompart Garcia, L. Viso Pons (Hospital Sant Joan
Desp�
ı Moises Broggi); D. Juli�
a, A. Codina-Cazador, R.
Farr�
es, N. G�
omez, P. Planellas (Hospital Universitari de
Girona Doctor Josep Trueta); M. Cuadrado, I. Camps
(Hospital
Universitari
Germans
Trias
I
Pujol);
M.
Rufas, J. Escoll, A. Fermi~
n�
an, P. Muriel, E. Sierra
(Hospital Universitario Arnau de Vilanova de Lerida);
C. Alvarez-Laso, P. Lora, H. Padin (Hospital Universi-
tario de Cabue~
nes); J. Garcia-Septiem, C. Bustamante,
V. Jimenez, J. Jimenez-Miramon, J. L. Ramos (Hospital
Universitario de Getafe); A. B. Gallardo, P. Benito, L.
Colao, P. Galindo, C. Garcia (Hospital Universitario de
Torrej�
on de Ardoz); A. Forero-Torres, A. Alonso Poza,
B. Dieguez Fernandez, C. Gilsanz Martin, M. Hernan-
dez Garcia (Hospital Universitario del Sureste); J. A.
Rojo L�
opez, J. M. Gil L�
opez, M. Gonz�
alez Zunz�
arren,
J. Mart�
ınez Alegre, L. P. Zorrilla Matilla (Hospital
Universitario Infanta Sofia); A. Navarro-S�
anchez, F. J.
Alcal�
a Serrano, J. L�
opez-Fern�
andez, D. Montesdeoca
Cabrera
(Hospital
Universitario
Insular
de
Gran
Canaria); M. Alvarez-Gallego, J. Guevara, I. Pascual
Miguela~
nez, I. Rubio-Perez (Hospital Universitario La
Paz); M. Gomez Ruiz, J. Alonso Mart�
ın, C. Cagigas
Fern�
andez, J. Castillo Diego (Hospital Universitario
Marques de Valdecilla); J. A. Pando, C. Maristany, A.
Mu~
noz-Duyos, A. Rada-Palomino, H. Vargas-Pierola
(Hospital Universitario Mutua Terrassa); E. Pe~
na Ros,
J. A. Benavides Buleje, J. M. Mu~
noz Camarena, P. A.
Parra Ba~
nos, M. Ramirez Faraco (Hospital Universitario
Reina Sof�
ıa); J. J. Arenal, M. A. Citores, J. L. Marcos,
J. S�
anchez, C. Tinoco (Hospital Universitario R�
ıo Hor-
tega); L. J. Garc�
ıa Fl�
orez, R. D. Arias Pacheco, G.
M�
ınguez Ruiz, N. Guti�
errez Corral, A. Rodr�
ıguez
Infante (Hospital Universitario San Agust�
ın); M. J. Car-
rillo L�
opez, M. M. Carrasco Prats, A. Lage Laredo, �
A.
Mart�
ınez
Manzano,
P.
Rodr�
ıguez
Garc�
ıa
(Hospital
Universitario Santa Lucia); J. J. Segura-Sampedro, N.
Alonso-Hern�
andez, M. Fernandez Isart, M. Gamundi
Cuesta, A. Ochogavia Segui (Hospital Universitario Son
Espases); N. Iba~
nez, J. Abrisqueta, J. Lujan (Hospital
Universitario Virgen de la Arrixaca); R. G�
omez P�
erez,
E. Corrales Valero, C. Monje Salazar, E. Sanchiz Carde-
nas, R. Soler Humanes (Hospital Universitario Virgen
de la Victoria); R. M. Jimenez-Rodriguez, F. De la Por-
tilla, J. M. Diaz Pavon, A. M. Garcia Cabrera, M. L.
Reyes Diaz (Hospital Universitario Virgen del Rocio);
E. Espin, F. Marinello, M. Mart�
ı, J. L. Sanchez, F. Vall-
ribera (Hospital Valle de Hebron); F. J. Orts Mico, M.
Ortin
Navarro,
M.
Perez
Climent,
C.
Serra
Diaz
(Hospital Virgen de los Lirios); M. Millan, A. Caro, J.
Escuder, B. Espina, F. Feliu (Joan XXIII University
Hospital); A. Climent Aira, A. Est�
evez Diz, M. T. Mor-
eno Asencio, A. Varela Mato, R. V�
azquez Bouz�
an
(POVISA Hospital); A. M. Minaya-Bravo, M.M. Diez-
Alonso, R. Villeta-Plaza (Principe de Asturias Hospital);
H. Guadalajara, D. Al�
ıas, D. Garc�
ıa Olmo, C. Pastor, I.
Valverde (Quironsalud Publicos); A. Sanchez Romero,
A. Gardea, M. Gil Santos, T. Nimmersgern, P. Serrano
Paz (Unidad de Coloproctorlogia, Hospital Vinalop�
o-
Torrevieja); M. Romero-Sim�
o, T. Blasco-Segura, I. Car-
avaca-Garc�
ıa, D. Costa-Navarro, A. Zarco-Pleguezuelos
(University General Hospital of Alicante); L. S�
anchez-
Guill�
en, B. Flor-Lorente, M. Frasson, �
A. Garc�
ıa-Gran-
ero, E. Garc�
ıa-Granero (University Hospital La Fe
Valencia); B. Arencibia, J. Alonso, G. Febles, E. M.
Nogu�
es,
C.
Roque
(University
Hospital
of
Gran
Canaria Dr. Negr�
ın).
Sweden: J. Segelman, J. Nygren (Ersta Hospital); G.
Nestler
(Falu
lasarett);
M.
Abraham-Nordling,
M.
Egenvall (Karolinska University Hospital); P. Myrelid,
B. Jung, P. Loft
�
as (Link€
oping University Hospital); M-
L. Lydrup, N. Azahr, P. Buchwald, P. Mangell, I. Syk
(Skane University Hospital); M. Nikberg, J. Carlander,
A.
Chabok,
K.
Smedh,
C.
Tiselius
(V€
astmanlands
Hospital V€
aster
�
as); S. Haapaniemi, A. Benckert (Vrin-
nevi Hospital Norrkoping).
Switzerland: M. Adamina, C. Freil-Lanter, C. Gin-
gert, P. M€
uller, J. Sch€
afli (Kantonsspital Winterthur); L.
Regusci, M. Brenna, F. Fasolini (Regional Hospital
Mendrisio); H. Misteli, P. Kirchhoff, D. Oertli (Univer-
sity Hospital Basel, Switzerland); D. Hahnloser, D.
Clerc, M. H€
ubner (University Hospital of Lausanne,
CHUV); F. Ris, N. C. Buchs, M. Chevallay, P. Morel,
B. Schiltz (University Hospitals Geneva).
Taiwan: J. Y. Wang, W-C. Su, C-W. Huang, C-J.
Ma, H-L. Tsai (Kaohsiung Medical University Hospi-
tal).
Turkey: D. Bugra (American Hospital); F. Agalar, H.
Baloglu, I. Basoglu (Anadolu Medical Center [in aff
with Johns Hopkins Med]); N. Okkabaz, E. Binboga,
A. Biricik, A. Celik, E. Yavuz (Bagcilar Training and
Research Hospital); A. E. Canda, C. Agalar, M. Fuzun,
S. Sokmen, C. Terzi (Dokuz Eylul University); A. Isik
(Erzincan University, Mengucek Gazi Training and
Research Hospital); B. Karip, A. C. Bilgili (Fatih Sultan
Mehmet Training and Research Hospital); S. Leven-
to�
glu, B. Aytac, E. K€
uc
�€
ukdiler, A. Yıldız, O. Yuksel
(Gazi University Medical School); H. Sinan, O. Hancer-
liogullari, S. Kaymak, O. Kozak, M. T. Ozer (Gulhane
Training and Research Hospital); I. S. Sarici, O. Akca,
M. U. Kalayci, Y. Kara (Kanuni Sultan Suleyman Train-
ing and Research Hospital); D. Bugra, O. Agcaoglu, E.
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
31
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
Combined bowel prep with oral antibiotics
 Balik, O. Bayram (Koc University School of Medicine);
G. S. €
Ozbalcı, B. B. €
Ozkan, U. Karabacak (On Dokuz
Mayis University Faculty of Medicine); U. Sungurtekin,
U. Ozgen (Pamukkale University School of Medicine);
S.
Demirbas
(TOBB-ETU
University
Hospital);
E.
€
Ozt€
urk, O. Isik, T. Yilmazlar (Uludag University School
of Medicine); E. Colak, S. Karagul, V. Kinas (University
of Health Sciences, Samsun Training and Research
Hospital).
UK: N. Fearnhead, I. Lord, P. Stewart (Adden-
brooke’s [Cambridge University] Hospital); M. Zammit
(Basildon Hospital); S. Arnold, N. J. Battersby, J.
Broadhurst, S. Moran, F. Seretis (Basingstoke and
North Hampshire Hospital); J. Shabbir, C. Jones, J.
Kynaston (Bristol Royal Infirmary); D. Vimalachandran,
E. Blower, C. McFaul, D. McWhirter, J. Pilkington
(Countess of Chester Hospital); T. Wilson, M. Chowd-
hary
(Doncaster
Royal
Infirmary);
B.
Stubbs,
M.
Abdalkoddus, C. Lai, N. Thavanesan, C. Yao (Dorset
County Hospital); T. Agarwal, S. Dindyal, R. M. C.
Hill, S. Reade, A. Slesser (Ealing Hospital); H. Pater-
son, A. Balfour, M. Boland, A. Geraghty, J. O’Kelly
(Edinburgh Western General Hospital); P. Patel, S.
Tezas (Furness General Hospital); S. Yahia, V. Jadhav,
K.
Marimuthu,
A.
Narayanan,
B.
Piramanayagam
(George Eliot Hospital); N. Bradley, F. Buchanan, K.
Paul, J. Singh, K. Thomson (Glasgow Royal Infirmary);
S. Korsgen, M. Bedford, K. Lee, K. Leong (Good
Hope Hospital); D. McArthur, A. Bhangu, S. Malik, I.
Mohamed (Heartlands Hospital); P. Cunha, A. Pilavas
(Homerton University Hospital NHS Trust); A. Reddy,
S. Ahmed, A. Ahmed, J. Voll (James Cook University
Hospital); V. Velchuru, R. Lal, B. Mirshekar-Syahkal
(James
Paget
Hospital);
M.
Kassai,
M.
Aleem,
S.
Keogh-Bootland (Jersey General Hospital); P. Sarmah,
S. Brown, R. Keegan, A. Kelkar, P. Sen (Kettering Gen-
eral Hospital); M. Oliveira-Cunha, S. Chaudhri, R.
Fares, B. Singh, W. M. Thomas (Leicester General
Hospital); M. I. Aslam, K. Boyle, D. Hemingway, A.
Miller, M. Norwood (Leicester Royal Infirmary); S.
Gurjar, M. Al-Saeedi, L. Anandan, A. Sudlow, N.
Zampitis (Luton & Dunstable Hospital); K. Malik, M.
Bogdan, C. Smart (Macclesfield District General Hospi-
tal); M. R. Iqbal, S. Bailey, D. Lawes, G. Omar, R.
Tamhane
(Maidstone
and
Tunbridge
Wells
NHS
Trust); M. Evans, S. Ather, J. Lim, H. Nageswaran, G.
Taylor
(Morriston
Hospital);
L.
Hunt, J.
Nicholls
(Musgrove Park Hospital); I. Shaikh, F. Muscara, J.
O’Brien, E. Photi, A. Stearns (Norfolk and Norwich
University Hospital); D. Meylemans, C. Cunningham,
R.
Hompes
(Oxford
University
Hospitals);
A.
Tennakoon, N. Kumarasinghe, M. Rao, I. Upanishad
(Pilgrim Hospital); J. Khan, N. Ahmad, Z. Shweejawee,
S. Stefan (Queen Alexandra Hospital); N. Smart, I.
Daniels, T. Gregoir, L. Longstaff, F. McDermott (Royal
Devon & Exeter Hospital); M. Varcada, I. Drami, T.
Gala, E. Moggia, K. Ratnatunga (Royal Free Hospital
NHS Trust Hampstead); R. Harries, J. Hayes, G. Wil-
liams (Royal Gwent Hospital); T. Raymond, C. Bron-
der, E. Davies, P. Hawkin, O. Ryska (Royal Lancaster
Infirmary); K. Ayral, A. Beveridge, A. Bhowmik, M.
Gill, R. Simpson (Royal Preston Hospital); A. Schofield,
K. McArdle, M. Parmar (Royal Shrewsbury Hospital);
M. Williamson, H. Burton, E. Courtney, C. Grant, A.
Saracino (Royal United Hospital Bath); K. Newton, J.
Epstein (Salford Royal NHS Foundation Trust); G.
Branagan, M. Bignell, M. Symankewicz (Salisbury Dis-
trict Hospital); S. Zaman, R. Mankotia, Z. Siddiqui, A.
Torrance (Sandwell General Hospital); D. Artioukh, M.
Eggleston, K. Gokul, D. Selwyn (Southport and Orm-
skirk Hospitals); J. Warusavitarne, P. Chandrasinghe, J.
Grainger , C. A. Leo, C. J. Vaizey (St Mark’s Hospital);
G. Harris, B. Levy, A. Skull (St Richard’s Hospital); M.
Thaha, S. Ahmed, A. Garg, H. Patel, A. Ramsanahie
(The
Royal
London
Hospital,
Barts
Health
NHS
Trust); M. Mondragon-Pritchard, K. Cuinas Leon, G.
Williams (The Royal Wolverhampton NHS Trust); A.
Shukla, H. Brewer, J. Fitzgerald, H. Kho (United Lin-
colnshire Hospitals NHS Trust); J. Torkington, S. Tate,
J. Wheat (University Hospital of Wales); S. Smolarek,
E. Platt, B. Rossi, J. C. Tham (University Hospitals Ply-
mouth NHS Trust); J. Knight, J. Richardson, A. Tzi-
vanakis
(University
Hospital
Southampton);
M.
Gregori, M. A. Ashraf, M. Atif, A. Birindelli, J. Santos
(University Hospitals Birmingham NHS FT); N. Saffaf,
M. I. Aslam, L. Canning (Warwick Hospital); N. Chan-
dratreya,
M.
Bowen,
B.
Graham,
Y.
Hamad,
M.
Kaubrys (Weston General Hospital at Weston super
Mare); Z. U. Chaudhry, C. Bhan, H. Mukhtar, A.
Oshowo, J. Wilson (Whittington Hospital NHS Trust);
J. Richardson, N. Gouvas, D. Nicol, S. Pandey, M. Zil-
vetti (Worcestershire Royal Hospital); A. Sharma, T.
Fatayer, S. Mothe, M. Rahman (Wythenshawe Hospital,
UHSM); N. Curtis, A. Allison, R. Dalton, N. Francis,
J. Ockrim (Yeovil District Hospital).
Ukraine: G. Psaras, H. Dudarovaska, T. Marharint,
E. Mostovoy, S. Voloshin (Mariupol Cancer Center);
O. Kolesnik, D. Makhmudov (National Cancer Insti-
tute, Ukraine).
United States: Y. Altinel (Cleveland Clinic); A. Iqbal,
L. Cunningham, K. Go, S. Tan (University of Florida).
Colorectal Disease ª 2018 The Association of Coloproctology of Great Britain and Ireland. 20 (Suppl. 6), 15–32
32
Combined bowel prep with oral antibiotics
The 2017 European Society of Coloproctology (ESCP) Collaborating Group
